Explore the vast range of titles available.

To clarify the relationship between earthquake occurrence and fluid, we analyzed data from a dense aftershock-observation network with 69 high-gain short-period seismographs installed immediately after the mainshock occurrence (October 21) in the aftershock area of the 2016 Central Tottori Prefecture earthquake. We determined the hypocenters and focal mechanisms of the aftershocks very precisely in the period from October 22 to December 15. We then investigated the temporal changes in the spatial distributions of hypocenters and T-axis azimuths of focal mechanisms. The distributions of aftershock hypocenters and T-axis azimuths are basically temporally stable, except those in limited portions in the shallow layer near the western edge of the aftershock area, where rapid decrease of aftershocks with T-axis azimuths of WSW to west was observed. If fluid rises from the lower crust due to fault rupture, the locations of aftershocks and focal mechanisms may change over time, especially in the deepest part of the aftershock region. However, the temporal change in these parameters was not apparent at depth. These observations suggest that the aftershock activity of the Central Tottori Prefecture earthquake was controlled mainly by stress concentration rather than strength reduction due to high fluid pressure.

After a large earthquake, many small earthquakes, called aftershocks, ensue. Additional large earthquakes typically do not occur, despite the fact that the large static stress near the edges of the fault is expected to trigger further large earthquakes at these locations. Here we analyse ~10,000 highly accurate focal mechanism solutions of aftershocks of the 2016 Mw 6.2 Central Tottori earthquake in Japan. We determine the location of the horizontal edges of the mainshock fault relative to the aftershock hypocentres, with an accuracy of approximately 200 m. We find that aftershocks rarely occur near the horizontal edges and extensions of the fault. We propose that the mainshock rupture was arrested within areas characterised by substantial stress relaxation prior to the main earthquake. This stress relaxation along fault edges could explain why mainshocks are rarely followed by further large earthquakes.

A long linear distribution of epicenters is seen along the Japan Sea coast in the San-in district located in southwestern Japan. This linear distribution of epicenters is called the seismic belt in the San-in district. The localization of intraplate earthquakes in the San-in district, far from plate boundaries, is not well understood. To answer this question, we look at the seismic velocity structure of the lower crust beneath the San-in district using seismic travel-time tomography. Our results show the existence of a low-velocity anomaly in the lower crust beneath the seismic belt. We infer that the deformation was concentrated in the low-velocity zone due to compressive stress caused by the subduction of oceanic plates, that stress concentration occurred just above the low-velocity zone, and that the seismic belt was therefore formed there. We also calculated the cutoff depths of shallow intraplate earthquakes in the San-in district. Based on the results, we consider the possible causes of the low-velocity anomaly in the lower crust beneath the seismic belt. We found that the cutoff depths of the intraplate earthquakes were shallower in the eastern part of the low-velocity zone in the lower crust beneath the seismic belt and deeper in the western part. Thus, the eastern part is likely to be hotter than the western part. We inferred that the eastern part was hot because a hot mantle upwelling approaches the Moho discontinuity below it and the resulting high temperature may be the main cause of the low-velocity anomaly. On the other hand, in the western part, we inferred that the temperature is not high because the mantle upwelling may not exist at shallow depth, and water dehydrated from the Philippine Sea plate reaches the lower crust, and the existence of this water may be the main cause of the low-velocity anomaly.

Background: The standard of care for unresectable, locally advanced non-small cell lung cancer (LA-NSCLC) is chemoradiotherapy (CRT) followed by durvalumab, based on the PACIFIC trial. Disease progression and pneumonitis were reported as the main reasons to preclude the initiation of durvalumab in multiple retrospective studies. However, the transition rate and the reasons for failure to proceed to consolidation therapy with durvalumab after CRT were not evaluated prospectively. Although phase II studies in Japan have shown high efficacy and tolerability of CRT with cisplatin + S-1 (SP), no prospective study using durvalumab after SP-based CRT has yet been reported. We therefore conducted a phase II study to verify the efficacy and safety of durvalumab following SP-based CRT. In this interim analysis, we report the transition rate and the reasons for its failure. Methods: In treatment-naïve LA-NSCLC, cisplatin (60 mg/m2, day 1) and S-1 (80–120 mg/body, days 1–14) were administered with two 4-week cycles with concurrent thoracic radiotherapy (60 Gy) followed by durvalumab every 2 weeks for up to 12 months. The primary endpoint was 12 month progression-free survival rate. Results: Fifty-nine patients were enrolled, of whom 86.4% (51/59) proceeded to durvalumab. All of them initiated durvalumab within 42 days after CRT [median 18 days (range: 3–38)], including 27.5% (14/51) in <14 days. Common reasons for failure to proceed to durvalumab were disease progression (2/59, 3.4%) and adverse events (6/59, 10.2%). Among the latter cases, four resumed treatment and proceeded to durvalumab within 42 days on off-protocol. The objective response rate and the disease control rate were 62.7% and 93.2%, respectively. The incidences of ⩾grade 3 pneumonitis, febrile neutropenia, and esophagitis were 0%, 8.5%, and 3.4%, respectively. Conclusion: Regarding durvalumab after CRT, this interim analysis of the SAMURAI study clarified the high transition rate, early introduction, and reasons for failure to proceed to consolidation therapy, which were not determined in the PACIFIC trial. Trial registration: Japan Registry of Clinical Trials, jRCTs031190127, registered 1 November, 2019, https://jrct.niph.go.jp/latest-detail/jRCTs031190127.

IntroductionDexamethasone (DEX) is administered for multiple days to prevent chemotherapy-induced nausea and vomiting for patients receiving highly emetogenic chemotherapy (HEC); however, its notorious side effects have been widely reported. Although our multicentre randomised double-blind comparative study verified non-inferiority of sparing DEX after day 2 of chemotherapy when combined with neurokinin-1 receptor antagonist (NK1-RA) and palonosetron (Palo) for patients receiving HEC regimen, DEX sparing was not non-inferior in patients receiving cisplatin (CDDP)-based HEC regimens in subgroup analysis. Recently, the efficacy of the addition of olanzapine (OLZ) to standard triple antiemetic therapy on HEC has been demonstrated by several phase III trials. This study aims to confirm non-inferiority of DEX sparing when it is combined with NK-1RA, Palo and OLZ in patients receiving CDDP-based HEC regimens.Methods and analysisThis is a randomised, double-blind, phase III trial. Patients who are scheduled to receive CDDP ≥50 mg/m2 as initial chemotherapy are eligible. Patients are randomly assigned to receive either DEX on days 1–4 or DEX on day 1 combined with NK1-RA, Palo and OLZ (5 mg). The primary endpoint is complete response (CR) rate, defined as no emesis and no rescue medications during the delayed phase (24–120 hours post-CDDP administration). The non-inferiority margin is set at −15.0%. We assume that CR rates would be 75% in both arms. Two hundred and sixty-two patients are required for at least 80% power to confirm non-inferiority at a one-sided significance level of 2.5%. After considering the possibility of attrition, we set our final required sample size of 280.Ethics and disseminationThe institutional review board approved the study protocol at each of the participating centres. The trial result will be presented at international conferences and published in peer-reviewed journals.Trial registration numberUMIN000032269.

Background: The standard of care for unresectable, locally advanced non-small-cell lung cancer (LA-NSCLC) is chemoradiotherapy (CRT) followed by durvalumab, based on the PACIFIC study. Although multiple Japanese phase II studies have shown high efficacy and tolerability of CRT with cisplatin plus S-1 (SP), no prospective study using durvalumab after SP-based CRT has been reported. Objectives: We conducted a multicenter phase II study of this approach, the interim analysis of which showed a high transition rate to durvalumab consolidation therapy. Here, we report the primary analysis results. Design: In treatment-naïve LA-NSCLC, cisplatin (60 mg/m2, day 1) and S-1 (80–120 mg/body, days 1–14) were administered with two 4-week cycles with concurrent thoracic radiotherapy (60 Gy) followed by durvalumab (10 mg/kg) every 2 weeks for up to 1 year. Methods: The primary endpoint was 1-year progression-free survival (PFS). The expected 1-year PFS and its lower limit of the 80% confidence interval (CI) were set as 63% and 47%, respectively, based on the results of TORG1018 study. Results: In all, 59 patients were enrolled, with 51 (86.4%) proceeding to durvalumab. The objective response rate throughout the study was 72.9% (95% CI: 59.7–83.6%). After median follow-up of 21.9 months, neither median PFS nor OS was reached. The 1-year PFS was 72.5% (80% CI: 64.2–79.2%, 95% CI: 59.1–82.2%), while the 1-year overall survival was 91.5% (95% CI: 80.8–96.4%). No grade 5 adverse events were observed throughout the study. The most common adverse event during the consolidation phase was pneumonitis (any grade, 78.4%; grade ⩾3, 2.0%). Eventually, 52.5% of patients completed 1-year durvalumab consolidation therapy from CRT initiation. Conclusion: This study of durvalumab after SP-based CRT met its primary endpoint and found a 1-year PFS of 73% from CRT initiation. This study provides the first prospective data on the prognosis and tolerability of durvalumab consolidation from the initiation of CRT. Trial registration: Japan Registry of Clinical Trials, jRCTs031190127, registered 1 November, 2019, https://jrct.niph.go.jp/latest-detail/jRCTs031190127

Background: Preterm births cause a large public-health burden, and air pollution is considered to be a potential risk factor. We evaluated the association between proximity to major roads (as an index for air pollution) and preterm births, classified by gestational age and specific clinical manifestations. Methods: Data on parental information and birth outcomes were extracted from the database maintained by the perinatal hospital in Shizuoka, Japan. We restricted the analysis to mothers who delivered liveborn single births from 1997 to 2008 (n = 14,226). Using the geocoded residential information, each birth was classified on its proximity to major roads. We estimated the multivariate-adjusted odds ratios and their 95% confidence intervals (CIs) for the association of proximity to major roads with preterm births, using logistic regression. Results: We found positive associations between proximity to major roads and preterm births at all gestational ages. Living within 200 m increased the risk of births before 37 weeks by 1.5 times (95% CI = 1.2—1.8), birth before 32 weeks by 1.6 times (1.1—2.4), and births before 28 weeks by 1.8 times (1.0—3.2). Proximity specifically increased the risk of preterm births with preterm premature rupture of the membranes and with pregnancy hypertension. Conclusions: This study demonstrates that exposure to traffic-related air pollution increases even the risk of preterm births of less than 30 weeks' gestational age and proposes a possible mechanism.

Background: Based on the results of the PACIFIC study, chemoradiotherapy followed by 1-year consolidation therapy with durvalumab was established as the standard of care for unresectable, locally advanced non-small-cell lung cancer (LA-NSCLC). However, some topics not foreseen in that design can be explored, including progression-free survival (PFS) and overall survival (OS) after the start of chemoradiotherapy, the proportion of patients who proceeded to consolidation therapy with durvalumab, and the optimal chemotherapeutic regimens. In Japan, the combination regimen of S-1 + cisplatin (SP), for which the results of multiple clinical studies have suggested a good balance of efficacy and tolerability, is frequently selected in clinical settings. However, the efficacy and safety of consolidation therapy with durvalumab following this SP regimen have not been evaluated. We therefore planned a multicenter, prospective, single-arm, phase II study. Methods: In treatment-naïve LA-NSCLC, two cycles of combination chemotherapy with S-1 (80–120 mg/body, Days 1–14) + cisplatin (60 mg/m2, Day 1) will be administered at an interval of 4 weeks, with concurrent thoracic radiotherapy (60 Gy). Responders will then receive durvalumab every 2 weeks for up to 1 year. The primary endpoint is 1-year PFS rate. Discussion: Compared with the conventional standard regimen in Japan, the SP regimen is expected to be associated with lower incidences of pneumonitis, esophagitis, and febrile neutropenia, which complicate the initiation of consolidation therapy with durvalumab, and have higher antitumor efficacy during chemoradiotherapy. Therefore, SP-based chemoradiotherapy is expected to be successfully followed by consolidation therapy with durvalumab in more patients, resulting in prolonged PFS and OS. Toxicity and efficacy results of the SP regimen in this study will also provide information important to the future establishment of the concurrent combination of chemoradiotherapy and durvalumab. Trial registration: Japan Registry of Clinical Trials, jRCTs031190127, registered 1 November 2019, https://jrct.niph.go.jp/latest-detail/jRCTs031190127

Regarding the fabrication of solar selective absorbers, the ability to create microstructures on top of metal surfaces is a promising technology. Typically, these materials are able to possess spectrally-selective absorption properties for high-temperature usage. Solar-selective absorbers that function at temperatures up to 700 °C and possess shallow honeycomb cylindrical microcavities coated with a metal-dielectric multi-layer have been investigated. Honeycomb array cylindrical microcavities were fabricated on W substrate with interference lithography and multi-layers consisting of Pt nano-film sandwiched by Al2O3 layers were created for a uniform coating via atomic layer deposition. The absorbance spectrum of fabricated samples reveals results consistent with a simulation based on a rigorous coupled-wave analysis method. A solar absorbance value of 0.92 and a hemispherical total emittance value of 0.18 at 700 °C was determined from the fabricated solar-selective absorber. Additionally, thermal stability of up to 700 °C was confirmed in vacuum.

Vertical fine structure of tropical temperature profiles in the upper troposphere was analyzed with data obtained by the global positioning system radio‐occultation limb‐sounding technique of the Constellation Observing System for Meteorology, Ionosphere, and Climate (COSMIC), which has very high vertical resolution and global coverage. Inversion layers in the upper troposphere were detected using a 1 year record taken during 2007. They are observed most frequently during the boreal summer over the Indian Ocean. The region has the characteristics of a shallow quasi‐stationary stable layer that is inclined from a horizontal surface; it is higher in the east and to the north of the equator. We also conducted statistical analysis with objective reanalysis data made by the European Center for Medium‐Range Weather Forecasts (ERA‐40, 1979–2001) and confirmed the presence of a warm anomaly that has a structure consistent with the stable layer detected by COSMIC analysis. We analyzed the three‐dimensional structure and relationship among the temperature, geopotential height, and wind field to discuss possible mechanisms for producing these quasi‐stationary structures from the viewpoints of response to the stationary heating of the Asian summer monsoon and equatorial trapped stationary Kelvin waves.